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The mysteries surrounding the ∼97–98% of the human genome that does not encode pro-
teins have long captivated imagination of scientists. Does the protein-coding, 2–3% of the
genome carry the 97–98% as a mere passenger and neutral “cargo” on the evolutionary
path, or does the latter have biological function? On one side of the debate, many commen-
taries have referred to the non-coding portion of the genome as “selﬁsh” or “junk” DNA
(Orgel and Crick, 1980), while on the other side, authors have argued that it contains the
real blueprint for organismal development (Penman, 1995; Mattick, 2003), and the mecha-
nisms of developmental complexity.Thus, this question could be referred to without much
exaggeration as the most important issue in genetics today.
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Historically, genetic approaches have very successfully determined
the function of a variety of biologically important regions of a
genome (usually called “genes”), based on necessary and sufﬁcient
linkage between relatively obvious alterations in a phenotype(s)
and speciﬁc changes in nucleotide sequence. The vast majority
of sequences identiﬁed in the genetic screens do correspond to
protein-coding portions of the genome. For example, most of the
changes associated with simple Mendelian genetic diseases harbor
mutations in exons of protein-coding genes or in the sequences
that prevent their proper assembly into mature transcripts (near
splice junctions;Cooper et al., 1995). Thus, at face value at least, the
non-coding portions of the genomedonot really seem to represent
a reservoir of biologically or medically relevant sequences.
However, this interpretation lacks intellectual closure, primar-
ily because of its counter-intuitive conclusion that almost all
of the DNA in every cell of our body has no function. Upon
closer examination, a number of reasons exist to explain why
the traditional genetics methods did not uncover the genotype–
phenotype relationships in thenon-codingportions of the genome
(Mattick, 2009). For example, in addition to the simple fact that
protein-coding regions have traditionally been the primary focus
of forward genetic screens, alteration of non-coding, presum-
ably regulatory regions, may impart more subtle phenotypes than
coding regions, which cause catastrophic component damage.
Non-coding regions could have a higher tolerance to sequence
changes compared to protein-coding regions, or a higher redun-
dancywithin cellularmachineries, functioning as amajor substrate
for evolutionary innovation and phenotypic radiation.
Answering the basic question of the functionality of the non-
coding portion of the genome has shifted more toward molecular
methods, speciﬁcally toward measuring the primary output of the
genome, the RNA. At its core, the central premise behind these
endeavors relies on the following concept: the only functional
“products” of a DNA sequence that we can identify are copies
of itself, either in the form of an RNA molecule or a DNA mole-
cule. Copying of DNA into DNA ensures replication, cell division,
and DNA repair, while copying of DNA into RNA transmits infor-
mation into cellular actions. Even if a regulatory DNA sequence
does not directly encode RNA – its function is still measured by the
eventual production of RNA from somewhere in the genome.And,
while cellular processes could affect the function of a sequence of
DNA in many different ways, by either covalent modiﬁcation of its
bases or non-covalent interaction with a plethora of DNA binding
proteins, RNA output remains the only known way for a cell to
use DNA-encoded information. The central posit of this concept
implies that if a sequence of DNA participates in the production
of some RNA or affects the quantity or type of the RNA produced,
then this sequence can be functional if the RNA product has a
function.
This basic hypothesis has led to several whole-genome RNA
mapping experiments done during the past decade – in effect, the
ﬁrst attempts at genome-wide “RNA Bookkeeping.” These unbi-
ased surveys of RNA relied on high-throughput technologies such
as tiling arrays and various sequencing methods (Rinn et al., 2003;
Bertone et al., 2004; Carninci et al., 2005, 2008; Kapranov et al.,
2005, 2007a,b; Birney et al., 2007). In essence, the goal of all these
experiments was to identify as many molecules of RNA or sites
of transcription as possible in a given tissue, and catalog them
into those whose localization to protein-coding regions of the
genome could explain their function, and those whose localiza-
tion could not. Surprisingly, the latter class grew into a pervasive
and highly numerous collection (see below for more details) and
became broadly dubbed as “dark matter” RNA (Johnson et al.,
2005).
Originally, “dark matter” RNA referred simply to RNA pro-
duced from the regions of genome without known function, yet
stable enough for detection (Johnson et al., 2005). Tiling arrays
(Kapranov et al., 2003) can identify regions of genome that give
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rise to RNA by virtue of hybridization to probes evenly spaced
throughout the non-repetitive portions of the genome. The result-
ing map of transcription speciﬁes a series of RNA producing
regions that could then be compared to the map of other genomic
features, such as exons of protein-coding genes. The fraction of
genomic sequence covered by such fragments located outside of
the exons estimated the complexity of the “dark matter” RNA
(Kapranov et al., 2002).
Typically, about 75% of all bases represented by all transcribed
fragments detected by tiling arrays in any given human cell-
line or tissue originated outside of exons of cytosolic polyA+
mRNAs, suggesting that “dark matter” transcription was prevalent
in human cells (Kapranov et al., 2007a). As might be expected,
this fraction was much higher for human nuclear RNA (Cheng
et al., 2005). The FANTOM consortium has shown that the mouse
genome could be pervasively transcribed, producing a very com-
plex transcript architecture (Carninci et al., 2005). After combin-
ing all available microarray and sequence-based data from all bio-
logical sources, the ENCODE consortium estimated that∼20% of
all humangenomic sequencemight function toproduceRNA(Bir-
ney et al., 2007). As a consequence of hybridization-based decon-
volution of complex mixtures of nucleic acids, the signal thresh-
olds of detection had to be set relatively high to prevent detection
of spurious cross-hybridization. This resulted in one of the dis-
advantages of these experiments: a signiﬁcant undercounting of
transcribed elements. For example, using rapid ampliﬁcation of
cDNA ends (RACE), a more sensitive method for measurement
of RNA output form speciﬁc loci, evidence of RNA production
was found at 75% of randomly chosen human genomic sequences
where RNA had not been detected by ENCODE consortium tiling
arrays: see Supplementary Table 2 of Birney et al. (2007). This
data suggested that the fraction of genome that gives to rise to
RNA could far exceed the 20% ﬁgure. Indeed, when combining
the regions of transcription detected by any method with the total
length of all introns (always transcribed to give rise to the mature
RNAs), ENCODE estimated that 93% of the human genome is
transcribed (Birney et al., 2007). Thus, the matter of detecting the
transcribed portion of the genome in stable RNA could depend
largely on the sensitivity of the technology used.
However, these experiments have always suffered fromcriticism
that the abundance of the“dark matter”RNAs in mammalian cells
could be trivial, in part because of the sensitivity of the techniques
used to detect and validate the “dark matter” transcription (van
Bakel et al., 2010, 2011). Indeed, these studies were mostly aimed
at giving an estimate of the fraction of genomic sequences rep-
resented in the “dark matter” RNA and thus tell us something
about its complexity, but not about its relative mass (Clark et al.,
2011). Perhaps “dark matter” had a very complex population of
RNA, and yet represented nothing more than a trivial fraction of
cellular RNA mass. Such a scenario might suggest that “dark mat-
ter”RNA resulted from non-consequential by-products of cellular
processes, consistent with the overall “junk DNA” label given to
the non-coding portions of the genome in general (Brosius, 2005;
Struhl, 2007; van Bakel and Hughes, 2009; van Bakel et al., 2010).
An opposite scenario, where the “dark matter” RNA population
was indeed complex and constituted a signiﬁcant mass of cellular
RNA,would on the other hand, suggest that this RNA could indeed
be an important and previously hidden component of the regu-
latory architecture controlling differentiation and development
(Mattick, 2003, 2004, 2011; Kapranov et al., 2007b; St Laurent and
Wahlestedt, 2007).
The advent of next generation sequencing technologies has
allowed for a digital output based count of reads representing
short (typically on the order of 25–100 bases) stretches of RNAs
from which they were derived (Cloonan and Grimmond, 2008;
Wang et al., 2009). By calculating the relative fraction of such
reads, one can estimate the relative mass of “dark matter” RNA
as a whole, or any speciﬁc RNA or transcribed region in the total
mass of the assayed RNA population. Despite the apparent sim-
plicity of this approach, the original estimates of the fraction of
non-exonic reads in human or mouse RNAseq experiments varied
signiﬁcantly, fromas little as 7% (Mortazavi et al., 2008) to asmuch
as 40–50% (Cloonan et al., 2008; Morin et al., 2008). A subsequent
report by van Bakel et al. (2010) attempted to directly estimate the
relative mass of the“dark matter”RNA and came to the conclusion
that it accounts for only 12% of the polyadenylated RNA mass in
human or mouse cells. In addition, this report also stated that the
same conclusions could be reached by the analysis of total RNA
(depleted for rRNA). One common feature of all these reports was
the usage of PCR ampliﬁcation as a part of the RNA preparation
for sequencing, which has the potential to alter the original pro-
ﬁle of the population (Mamanova et al., 2010; Raz et al., 2011;
Sam et al., 2011). Thus, unequivocal estimation of the relative
mass of the “dark matter” RNA would require RNA proﬁling
using a sequencing approach that does not rely on ampliﬁca-
tion. Such proﬁling performed using single-molecule sequencing
of total rRNA-depleted RNA and polyA+ RNA (Kapranov et al.,
2010) found that “dark matter” RNA represents a majority of the
total non-ribosomal non-mitochondrial RNA most of the human
cell-lines and tissues tested (Kapranov et al., 2010). In addition,
total human RNA contained a much higher complexity than the
polyA+ RNA, especially in terms of “dark matter” RNAs (Kapra-
nov et al., 2010; Raz et al., 2011). This could also explain at least in
part the failure of some of the earlier reports to detect a signiﬁcant
fraction of the “dark matter” RNA: not only did those reports rely
on PCR ampliﬁcation, but also they used an RNA fraction highly
enriched for polyadenylated RNAs.
Interestingly, very long (100s of kbs) stretches of intergenic
space in the humangenome,previously considered as“gene desert”
regions produced signiﬁcant levels of RNA (Kapranov et al., 2010).
Hundreds of such regions (named vlincs for very long inter-
genic non-coding regions) spanning∼4%of intergenic space were
detected in just nine different biological sources of RNA (seven
tumors and two normal tissues) used in that report. This com-
bined with the observation that most of the vlincs tend to be
highly speciﬁc to a given biological source (Kapranov et al., 2010),
suggests that proﬁling of the pool of total cellular RNA with hun-
dreds or thousands of different biological samples would result in
detection of RNA from a large fraction of intergenic space. This
assertion is supported by in-depth analysis of selected genomic
regions using methods to select and enrich for all transcripts
derived from such regions followed by either tiling array analysis
or deep sequencing (Kapranov et al., 2005; Mercer et al., 2011a).
Such studies reveal that what appears to be a low signal from
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either a tiling array or RNAseq experiment obtained on a complex
RNA population from a single cell, can in fact represent a complex
population of low abundant transcripts (Kapranov et al., 2005;
Mercer et al., 2011a). Low abundance could also imply expres-
sion restricted to a sub-set of cells in a given population (from
a cell-culture or especially, a tissue sample), and thus should not
immediately be relegated into the realm of biological noise. These
observations are important to keep in mind when interpreting the
results of RNAseq or microarray experiments, especially consid-
ering that most current RNAseq experiments produce far fewer
reads than the estimated minimum of ∼70 million reads required
to completely cover the transcriptome from an average human cell
(Kapranov et al., 2010).
These results are consistent with those of the ENCODE consor-
tium as far as pervasive transcription is concerned. However, they
differ in the estimate of how much stable RNA would remain from
that pervasive transcription. The ENCODE consortium suggests
that only on the order of ∼20% of human genomic sequence ever
exists as stable RNA based on compilation of all available exper-
imental data from a large number of biological sources (Birney
et al., 2007). However the logical extrapolation from Kapranov
et al. (2010) would suggest that most of the genomic sequence
likely exists in the RNA pool when proﬁling a signiﬁcant number
of tissues using total rRNA-depleted RNA, instead of the polyA+
fraction. The discrepancy may result from the fact the ENCODE,
like other similar endeavors before and after, focused on the
polyadenylated fraction of RNA, that is estimated to capture only
5–25% of the total mass of the non-ribosomal non-mitochondrial
RNA in a human (Kapranov et al., 2010; Raz et al., 2011). Clearly,
the dominance of polyA+ RNA as the source of RNA for RNAseq
experiments has signiﬁcantly undercounted the complexity of
RNA present in a human cell. In fact, an oligo-dT column may
also not necessarily capture all the polyadenylated RNAs in a sam-
ple. For example, one can imagine that, long polyadenylated RNA
molecules may not bind efﬁciently due to structural interference,
resulting in depletion from the polyA+-selected RNApool. In fact,
depletionof longermRNAs inpolyA+RNApool occurs (Raz et al.,
2011).
Still, the wider question of functionality of non-polyadenylated
RNA as a class has received very little attention, and still remains
un-answered. The absence of a polyA-tail does not mean absence
of function – clearly, most short non-coding RNA species are
non-polyadenylated and functional, for example tRNAs, miRNAs,
snRNAs, and other classes of short RNAs. Furthermore, the pres-
ence of complex non-adenylated RNA populations in mammalian
cells has been established back in 1970s (Salditt-Georgieff et al.,
1981) and this type RNA occurred even in the polysomal frac-
tion and was shown to be used for protein production (van Ness
et al., 1979; Katinakis et al., 1980). More recently, a reporter mRNA
engineered to contain a miRNA in its 3′ UTR served as a target for
cleavage by Drosha into a polyA− RNA, and then traveled to the
cytosol to function as a template for protein production (Cai et al.,
2004). Thus, absence of the polyA-tail does not preclude RNAs
from having a function in the cell. However, we are still at the very
beginning of the exploration of the functional properties of the
vast complexity of novel and apparently non-polyadenylated RNA
recently discovered.
Perhaps one of the greatest hurdles in accepting the biologi-
cal relevance of “dark matter” transcription is the fact that a large
proportion of it comes from intronic regions of already annotated
genes. Based on single-molecule RNAseq data, it is estimated that
the intronic “dark matter” RNA constitutes 70–80% of all mass
of the human “dark matter” RNA (Kapranov et al., 2010). The
report van Bakel et al. (2010) obtained a similarly high estimate
of the fraction of the intronic RNA, but proposed that it simply
represents un-processed pre-mRNA. This conclusion was further
supportedby thedata presented in that reportwhere the fractionof
intronic RNA amounted only 5.8% of the mass of the human cell’s
total RNA not including the ribosomal and mitochondrial RNA
(van Bakel et al., 2010). However, as mentioned above, this esti-
mate could result from the choice of polyadenylated RNA used in
that study, combined with the effect of PCR ampliﬁcation. Single-
molecule sequencing of total RNA revealed a much higher fraction
of intronic RNAs in a human cell, on the order of 30–50% of non-
ribosomal, non-mitochondrial RNA (Kapranov et al., 2010). The
latter estimate should at least cause us to pause before any unam-
biguous acceptance of the trivial explanation above – as much as
half of nuclear-encodednon-ribosomal RNA in the cell is probably
not something one should dismiss outright as noise. In addition,
different genes vary in terms of how much intronic RNA they pro-
duce, as do different introns of the same gene, and even different
regions of the same intron (Kapranov et al., 2010). These obser-
vations are not consistent with noise expected from pre-mRNA
en-route to splicing or excised introns en-route to degradation.
Furthermore, intronic signal does not necessarily mean that it
arises from excised introns or pre-mRNA. Since RNAseq does
not provide information on the complete structure of an RNA
molecule, we do not know what kind of transcripts make up the
intronic signal observed in RNAseq experiments. In fact, it could
represent different types of elements: alternative exons, exon iso-
forms of known transcripts, independent stand-alone transcripts,
or excised introns (Figure 1). Moreover, one can imagine that any
given gene could have a collection of such different types of novel
transcripts buried in its introns (Mattick, 1994; Kapranov et al.,
2005). Overall, it is fair to say that we are at the beginning of our
understanding of role of intronic RNAs in a cell and we should
maintain an open mind as to its functional importance (Clark
et al., 2011).
Another class of sequences deserves special mention in the
context of the transcriptional activity of genomic “dark matter” –
the repetitive regions of a genome, which until very recently had
been largely avoided by genome-wide RNA proﬁling studies for
technical reasons. For example, tiling microarray designs typi-
cally exclude these regions (Kapranov et al., 2007a) because the
signal from the probes cannot resolve into an attribute for a spe-
ciﬁc repeat element. However, the nucleotide-level precision of
the next generation sequencing technologies allows mapping of
reads with a relatively high speciﬁcity, even to repeat regions of the
genome. This in turn allows for interrogation of RNAs produced
from repeats. For example, one such study relied on mapping
of CAGE tags that mark the 5′ ends of capped RNAs (Kodzius
et al., 2006) to proﬁle expression of different types of repeats in
mammalian cells (Faulkner et al., 2009). Interestingly, a signiﬁ-
cant fraction of transcription in that study coincided with repeats.
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FIGURE 1 |Types of RNA molecules derived from annotated and unannotated loci that constitute “dark matter” RNAs.
Different tissues express different levels and types of repetitive ele-
ments, with embryonic tissues having the highest levels of CAGE
tags (Faulkner et al., 2009). Interestingly, that study also found
that a certain class of repetitive elements, retrotransposons, might
provide alternative or tissue-speciﬁc promoters for protein-coding
genes (Faulkner et al., 2009), and a recent paper has shown that
these sequences mobilize to effect somatic transposition events in
the human brain (Baillie et al., 2011).
However, the last decade of transcriptome exploration also
revealed additional dimensions of its complexity. The ﬁrst added
level of complexity arises from the fact that any given locus can
be criss-crossed by different transcripts on both strands, described
as “transcriptional forests” by the RIKEN researchers after a large
scale effort aimed at sequencing full-length cDNAs from mam-
malian samples (Carninci et al., 2005). The transcriptional forests
are common in the protein-coding loci, where the transcripts
that form the complex lattices of overlapping transcription often
borrow sequences from known exons and non-exonic regions;
however, the function of most of the additional RNA isoforms,
which are presumably context-speciﬁc, is not understood. For
example, based on EST evidence, the GENCODE consortium has
shown that a human protein-coding locus speciﬁes on average 5.4
isoforms (Harrow et al., 2006). However, only 2.4 of those could
encode a protein, while the function of the rest remains an enigma
(Harrow et al., 2006).
Other studies have reached similar conclusions using RACE
in combination with tiling arrays to proﬁle the complexity of
transcripts sharing exons of ∼400 human protein-coding genes
(Birney et al., 2007; Denoeud et al., 2007). More than 80% of all
transcripts had alternative 5′ ends or novel exons (Denoeud et al.,
2007). In-depth analysis of one human locus encoding the MeCP2
proteins using the RACE/array method revealed 15 new isoforms
that have exons derived from intronic and intergenic sequences
with often perfectly correct splice sites (Djebali et al., 2008). In
most cases, however, additional isoforms identiﬁed either do not
appear to change the open reading frame or do not encode pro-
teins (Denoeud et al., 2007; Djebali et al., 2008), consistent with
previous GENCODE results (Harrow et al., 2006).
The recent realization that RNA could be cleaved and capped at
the newly formed 5′ end to produce a separate stable RNA species
provides an additional conceptual dimension of the complex-
ity of the mammalian cell’s RNA population (Affymetrix/CSHL
ENCODE Project, 2009; Otsuka et al., 2009; Mercer et al., 2010,
2011b). This opens a whole new realm of possibilities where the
ﬁnal, apparently mature and spliced RNA species may not rep-
resent the ﬁnal and/or the only functional product. Conversely,
shorter RNAs that would otherwise be considered as simple degra-
dation products, may have function. One tantalizing possibility
suggests that they might function in a manner similar to that
observed in RNA-mediated inheritance, carried out by apparent
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RNA degradation products loaded into germ line cells to medi-
ate regulation of gene expression in the subsequent generation of
mice (Rassoulzadegan et al., 2006).
Taken together, all of these added complexities suggest a com-
plete reconsideration of the deﬁnition of RNA “dark matter.” We
would like to posit that it includes not just the RNAs that are
made from the “dark matter” regions of the genome, but any RNA
molecule whose function we do not understand (Figure 1). For
example, an RNA molecule consisting solely of exons of an oth-
erwise protein-coding transcript, but spliced into an RNA with
no open reading frame, can be considered as an RNA mole-
cule whose function we do not understand, even though it is
assembled from individual sequences with known function. Like-
wise, an RNA molecule processed from a protein-coding gene
or pseudogene and having lost its protein-coding capacity can
be considered a “dark matter” transcript as long as we do not
understand its function. The “dark matter” RNAs can therefore
comprise both coding and non-coding RNAs, as long as their
function currently remains unclear. While, for the most part,
“dark matter” RNAs have features of non-coding RNAs (Carn-
inci et al., 2005; Cheng et al., 2005; Djebali et al., 2008), it
remains possible that some of the RNAs previously considered
as non-coding do encode short peptides (Kondo et al., 2010). In
fact, recent results based on proﬁling of sites in RNA molecules
bound by ribosomes suggest thatmanymouse“darkmatter”RNAs
indeed encode short peptides (Ingolia et al., 2011). Undoubt-
edly, the prevalence and biological relevance of these peptides
will remain a very interesting and important question for years
to come.
If the entire genome is transcribed and represented as stable
RNAs at least in some biological samples, then we should re-
evaluate as a community our strategies in terms of annotating the
“dark matter” RNAs. Despite the ongoing efforts to annotate the
lncRNAs (Amaral et al., 2011; Cabili et al., 2011; Chen et al., 2011;
Wang and Chang, 2011), the lists obtained from different exper-
iments do not overlap signiﬁcantly. For example, only ∼19% of
base pairs covered by the human vlinc regions in the intergenic
space overlap those found by lncRNAs (Kapranov et al., 2010; also
see Figure 2A). This suggests that current databases only scratch
the surface of the immense complexity of the RNA population of
human cells.
In retrospect, this is not surprisingwhen one considers that cur-
rent genomic annotations, such as the human GenBank mRNA
track on the UCSC browser (Kent et al., 2002), depend primar-
ily on sequenced full-length cDNAs, each one representing only a
single-molecule of RNA. GenBank currently contains∼300K such
FIGURE 2 | Coverage of the genome by “dark matter” RNAs. (A)
Information currently available about the regions of dark matter transcription
and the actual RNA molecules made from these region comes from various
types of experiments and databases. There is relatively little overlap between
these different databases suggesting that the actual extend of dark matter
transcription is far greater than any one database suggests. (B) A theoretical
curve showing expected results of the fraction of the genome that is
transcribed as a function of the number of biological sources whose RNA is
proﬁled. The coverage of transcribed genome by protein coding genes
including their introns is 42% and lincRNAs bring it up to 58%. However, the
full extent of the transcribed genome is expected to be much greater than
that.
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entries, which closely approximates estimates of the total num-
ber of polyadenylated RNA molecules contained in a single cell
(∼300K; Hastie and Bishop, 1976). Thus, based on these numbers,
it is fair to say that all we know in terms of the complete sequences
of RNAs from the human transcriptome represents just one cell’s
worth of polyadenylated RNA! Of the 300K human GenBank
mRNA entries,∼88% are represented by unique cDNAs, pointing
to the fact that many of the current gene models and annotations
are based on a single (!!!) fully sequenced RNA molecule. This is
reinforced by the recent application of targeted RNA sequencing,
which revealed a plethora of new coding and non-coding tran-
scripts, even from intensively studied human loci such as p53,
HOX, and sonic hedgehog (SHH) that are either only expressed in
a very limited number of cells in what was previously considered
a homogenous culture, or where otherwise missed in the cDNA
libraries (Kapranov et al., 2005; Mercer et al., 2011a). In addition,
most of the annotated cDNAs have been characterized from the
polyadenylated transcriptome, thus the non-polyadenylated frac-
tion remains virtually un-uncharted from the point of view of
full-length cDNA sequencing. Considering how many molecules
of RNA a given human locus must make during the lifetime of an
individual, evidently, this depth of knowledge only scratches the
surface of RNA complexity.
Finally, we believe that understanding of the true extent and
function of human transcription remains one of the most impor-
tant philosophical and scientiﬁc questions of our time. Consid-
ering this, we suggest that the community should undertake a
directed approach aimed at answering this question. We envision
the proﬁling of a reasonably large number of carefully chosen sam-
ples based on total RNA depleted of rRNA, rather than polyA+,
using ampliﬁcation freeRNAseq approaches.Given thehigh-tissue
speciﬁcity of dark matter RNAs, samples would include at least
100–200 key tissues or cell-lines, rich in intergenic RNAs, such
as Ewing Sarcomas. We expect the curve of detected dark matter
transcripts to reach a plateau steeply – the big un-answered ques-
tion so far is where this plateau will be and how much further the
curve will rise as more samples are added (Figure 2B). RNAseq
will yield regions of transcription, while additional methods will
unravel the complexities of individual transcripts in each region
of transcription. This could be accomplished by a site-directed
methods similar to the one described by Djebali et al. (2008).
As our understanding of the function of the novel RNA
expands, the domain of “dark matter” transcripts will shrink.
Unfortunately, for the most part we cannot yet predict in silico
which of these“non-canonical”RNA molecules are functional and
what function they might fulﬁll, like we usually can for protein-
coding mRNAs. This is probably the greatest challenge to our
understanding and acceptance of this type of RNA – our general
inability to predict what an RNA species might do when it does
not have an obvious open reading frame. However, this should not
stop us from exploring the function of these RNAs in biological
or medical context. Even if a function of a given RNA molecule
or transcribed region in a genome may not be known, its associa-
tion with a disease should provide novel mechanistic insights, and
novel diagnostic tools for the disease. The fact that “dark matter”
RNAs tend to be highly speciﬁc to their biological source empha-
sizes the promise of this approach (Cheng et al., 2005; Kapranov
et al., 2010). Surprisingly perhaps, it seems remarkably easy to
detect phenotypes associated with siRNA-mediated knockdown
or over-expression of non-coding RNAs, even in cell-culture, and
to correlate these phenotypes with aberrant expression of the
non-coding RNAs in disease states like cancer and neurological
diseases (see, e.g., Mattick, 2009; Gupta et al., 2010; Askarian-
Amiri et al., 2011; Gibb et al., 2011; Khaitan et al., 2011; Ulitsky
et al., 2011). Moreover, one of the ﬁrst examples of association
of “dark matter” transcripts emanating from a family of repetitive
regions with a particular type of cancer has been recently pro-
vided by Ting et al., 2011. Overall, it would not be surprising if
“dark matter” transcripts would eventually occupy a central place
in our conceptual understanding of the molecular events underly-
ing human development and disease, and thereby enter the arsenal
of therapeutic targets as prominently as those gene productswhose
function we currently understand.
GLOSSARY
CAGE: cap analysis of gene expression, a method based on selec-
tion of RNAs containing the 5′ CAP modiﬁcation and obtaining
short sequences or tags near the 5′ end of these RNAs. Typically,
millions of tags are obtained in each experiment.
ENCODE: encyclopedia of DNA elements, an NHGRI-
sponsored project aimed at empirically identifying functionally
important element in the human genome sequence, http://www.
genome.gov/10005107.
Genomic dark matter: usually refers to the portion of a genome
that does not correspond to exons (coding or non-coding) of
annotated mRNAs.
RACE: rapid ampliﬁcation of cDNA Ends, a PCR-approach
with “outward” positioned primers to amplify toward the 5′ and
3′ end of an RNA molecule from a point inside the molecule.
RNAseq: a method to quantify and proﬁle RNA population in
a cell based on massive sequencing of short (typically less than
100 bases) regions of a large number of RNA molecules. Typi-
cally, sequencing is conducted on cDNA, rather than RNA, thus
cDNAseq would have been more appropriate. However, RNAseq
is used for historical reasons. A note, since direct RNA sequencing
is now possible, a bona ﬁde RNAseq analysis should somehow be
distinguished from cDNAseq.
Single-molecule sequencing: amethodwhere a single-molecule
of a nucleic acid is sequenced directly as opposed methods that
obtain sequence signal from a population of molecules.
Tiling array: a microarray platform designed to interrogate
genomic sequence with a certain resolution set by the distance
between the probes. Opposite in concept to exon arrays where
probes are designed only to the annotated regions of interest.
Vlinc: very long intergenic non-coding RNA region, identiﬁed
based on continuous RNAseq signal that spans genomic regions of
50 kb or longer (often much longer) in the area of genome where
no annotated gene has been found.
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